6.08

0.50% 0.03

After Hours: 6.30 0.22 +3.62%

Verastem Inc (VSTM)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Verastem Inc stock is traded at $6.08, with a volume of 2.24M. It is up +0.50% in the last 24 hours and up +60.85% over the past month. Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.

Previous Close:

$6.05

Open:

$6.17

24h Volume:

2.24M

Relative Volume:

0.87

Market Cap:

$534.27M

Revenue:

$30.91M

Net Income/Loss:

$-209.47M

P/E Ratio:

-1.827

EPS:

-3.3279

Net Cash Flow:

$-147.13M

1W Performance:

+5.74%

1M Performance:

+60.85%

6M Performance:

-6.46%

1Y Performance:

-0.98%

1-Day Range:

$6.065

$6.4643

1-Week Range:

$5.70

$6.4643

52-Week Range:

$3.43

$11.24

Verastem Inc Stock (VSTM) Company Profile

Name

Verastem Inc

Sector

Healthcare (1074)

Industry

Biotechnology (599)

Phone

(781) 292-4200

Address

117 KENDRICK STREET, NEEDHAM, MA

Employee

102

Twitter

@VerastemOncolog

Next Earnings Date

2026-08-06

Latest SEC Filings

VSTM's Discussions on Twitter

Compare VSTM vs VRTX, REGN, ARGX, RVMD, ALNY

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
VSTM Verastem Inc	6.08	531.64M	30.91M	-209.47M	-147.13M	-3.3279
VRTX Vertex Pharmaceuticals Inc	479.00	121.16B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	667.17	68.78B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	888.82	57.44B	4.16B	1.29B	734.26M	19.58
RVMD Revolution Medicines Inc	188.07	40.23B	742.00K	-1.37B	-1.07B	-7.0731
ALNY Alnylam Pharmaceuticals Inc	278.40	36.28B	4.29B	577.22M	641.34M	4.2086

Verastem Inc Stock (VSTM) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Mar-12-26	Resumed	BTIG Research	Buy
Feb-04-26	Initiated	H.C. Wainwright	Buy
Oct-16-25	Resumed	Cantor Fitzgerald	Overweight
Apr-10-25	Initiated	Jefferies	Buy
Mar-24-25	Reiterated	H.C. Wainwright	Buy
Dec-31-24	Reiterated	BTIG Research	Buy
Sep-30-24	Initiated	Guggenheim	Buy
Nov-21-23	Resumed	BTIG Research	Buy
Sep-27-23	Initiated	B. Riley Securities	Buy
Jun-15-23	Upgrade	Mizuho	Neutral → Buy
Sep-07-22	Resumed	Alliance Global Partners	Buy
Apr-29-22	Resumed	Cantor Fitzgerald	Overweight
Apr-14-22	Initiated	RBC Capital Mkts	Outperform
Mar-09-22	Initiated	Truist	Buy
Jul-01-21	Initiated	Alliance Global Partners	Buy
May-24-21	Upgrade	BTIG Research	Neutral → Buy
Jun-20-19	Downgrade	BTIG Research	Buy → Neutral
May-10-19	Downgrade	Raymond James	Outperform → Mkt Perform
Jul-13-18	Initiated	BTIG Research	Buy
May-02-18	Initiated	Seaport Global Securities	Buy
Mar-08-18	Initiated	B. Riley FBR, Inc.	Buy
Sep-07-17	Reiterated	H.C. Wainwright	Buy
Apr-13-17	Initiated	Oppenheimer	Outperform
Mar-24-17	Reiterated	H.C. Wainwright	Buy
Sep-29-15	Downgrade	Cantor Fitzgerald	Buy → Hold
Sep-29-15	Downgrade	JMP Securities	Mkt Outperform → Mkt Perform
Sep-29-15	Downgrade	Jefferies	Buy → Hold
Sep-29-15	Downgrade	Raymond James	Strong Buy → Outperform
Sep-28-15	Downgrade	Mizuho	Buy → Neutral
Sep-28-15	Downgrade	ROTH Capital	Buy → Neutral
Sep-09-15	Initiated	Raymond James	Strong Buy
May-12-15	Reiterated	UBS	Buy
Apr-08-15	Initiated	H.C. Wainwright	Buy
Jan-23-15	Reiterated	ROTH Capital	Buy
Jul-08-14	Resumed	Oppenheimer	Perform
Feb-11-14	Initiated	Mizuho	Buy

View All

Verastem Inc Stock (VSTM) Latest News

Jul 27, 2026